Stratasys (SSYS) Launches Digital Anatomy Creator Software

Stratasys SSYS recently announced the launch of a new software module — Digital Anatomy Creator — designed for its Digital Anatomy 3D Printers to enhance personalized healthcare through anatomic modeling solutions.

The software enables healthcare providers to easily manipulate material formations and customize their prints’ eternal structures for patient-specific anatomic models, which are a replication of the patient’s pathologic and biologic anatomy.

With the Digital Anatomy Creator, the users will be able to create, explore and share ultra-realistic designs of patient-specific anatomies across communities. They will be able to access additional options and controls to calibrate printing materials, thus fulfilling user-specific, personalised, anatomic model requirements.

Stratasys collaborated with Synopsys’ SNPS Simpleware ScanIP Medical and Materialise’s MTLS Mimics inPrint to certify its Digital Anatomy and J5 MediJet printers to be included in FDA 510(k) cleared medical modeling workflows. This will give customers access to digital workflows for diagnostic anatomic modeling and enhance point-of-care 3D printing.

Of late, Stratasys has been expanding its materials ecosystem across P3, Selective Absorption Fusion (“SAF”), and stereolithography 3D printing systems. Recently, in November, it launched an Open Material License to advance its manufacturing strategy with a new open tier of third-party materials for FDM 3D printers. This enabled its manufacturing customers to address new applications with demanding requirements, while having dual material sources.

In October, Stratasys introduced GrabCAD Additive Manufacturing Platform, an open and enterprise-ready software platform that enables manufacturers to manage production-scale additive manufacturing operations.

In September, the company introduced an Open Material License for the P3-based Origin One along with two new materials from Loctite by Henkel. Earlier, in June, it expanded its software ecosystem with the addition of Teton Simulation, which utilizes GrabCAD DFAM Software Development Kit to help customers improve the reliability of additive manufacturing builds.

Stratasys, Ltd. Price and Consensus

Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote

Zacks Rank & Stocks to Consider

Stratasys and Synonpsys currently carry a Zacks Rank #3 (Hold), while Materialise sports a Zacks Rank #1 (Strong Buy). Shares of SSYS and SNPS have appreciated 30.4% and 37.3%, respectively, while MTLS has depreciated 56.1% in the year-to-date (“YTD”) period.

A better-ranked stock in the broader technology sector includes Advanced Micro Devices AMD, which carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Advanced Micro Devices’ fourth-quarter 2021 earnings has been revised upward by 8 cents to 76 cents per share over the past 60 days. For 2021, earnings estimates moved north by 15 cents to $2.65 per share in the last 60 days.

Advanced Micro Devices’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 14%. Shares of AMD have rallied 76.5% in the YTD period.

Investor Alert: Legal Marijuana Looking for big gains?

Now is the time to get in on a young industry primed to skyrocket from $13.5 billion in 2021 to an expected $70.6 billion by 2028.

After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could kick start an even greater bonanza for investors. Zacks Investment Research has recently closed pot stocks that have shot up as high as +147.0%.

You’re invited to immediately check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.